<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04628442</url>
  </required_header>
  <id_info>
    <org_study_id>19-28725</org_study_id>
    <secondary_id>2P01HL107202-06A1</secondary_id>
    <nct_id>NCT04628442</nct_id>
  </id_info>
  <brief_title>Tissue Immune Interaction in Nasal Polyposis</brief_title>
  <acronym>TIP</acronym>
  <official_title>Tissue Immune Interaction in Nasal Polyposis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a cross-sectional study of up to 100 subjects who are undergoing clinically indicated&#xD;
      sinus procedures to treat chronic rhinosinusitis. Participants will be asked to donate&#xD;
      leftover sino-nasal secretions, sino-nasal tissue and blood as well as undergo partial&#xD;
      characterization. As optional extensions of the main study, participants may also undergo a&#xD;
      biopsy of extra sino-nasal tissue for additional tissue analysis and/or a more detailed&#xD;
      characterization visit performed in the UCSF Airway Center Research Center (ACRC).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a cross-sectional study of up to 100 participants who are undergoing clinically&#xD;
      indicated sinus procedures to treat chronic rhinosinusitis. 50 participants with CRSwNP and&#xD;
      50 participants with CRS without polyps and no features of atopy will be enrolled in the&#xD;
      study. Participants will donate leftover sino-nasal secretions and tissue from their&#xD;
      procedures. In addition, participants will be subject to medical record review and research&#xD;
      questionnaires.&#xD;
&#xD;
      In many instances, these participants will have multiple procedures over time to treat&#xD;
      recurrent disease and this study will allow for them to donate leftover biospecimens as many&#xD;
      as 9 times.&#xD;
&#xD;
      Participants may also opt to undergo a turbinate mucosal tissue biopsy during regularly&#xD;
      scheduled sinus surgery for additional tissue analysis and/or undergo a more detailed,&#xD;
      complete characterization visit performed in the UCSF Airway Center Research Center (ACRC).&#xD;
      During the complete characterization, participants will undergo lung function tests, sputum&#xD;
      induction and blood collection, in addition to the procedures mentioned above.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 10, 2020</start_date>
  <completion_date type="Anticipated">March 2025</completion_date>
  <primary_completion_date type="Anticipated">March 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of ILC2 and tuft cells</measure>
    <time_frame>Up to 8 hours</time_frame>
    <description>This study enrolls chronic rhinosinusitis patients with and without nasal polyps. Investigators aim to compare the percentage of ILC2 and tuft cells present in nasal tissue and secretions between those who present with nasal polyps and without nasal polyps.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Chronic Rhinosinusitis (Diagnosis)</condition>
  <condition>Chronic Rhinosinusitis With Nasal Polyps</condition>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>TIP-OB (Office-Based)</arm_group_label>
    <description>Those in TIP-OB will be undergoing regularly scheduled office-based procedures at the otolaryngology clinic at UCSF Mount Zion campus. The investigators will be collecting nasal mucus and blood samples during each of their visits to the clinic, up to 9 times.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TIP-OR (Operating Room)</arm_group_label>
    <description>Those in TIP-OR will be undergoing regularly scheduled surgeries in the operating room at UCSF Parnassus or Mount Zion campus. The investigators will be collected nasal polyp tissue, nasal mucus if possible, and blood samples during each of their surgeries, up to 9 times. The investigators will also collect inferior turbinate tissue if consented to.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sinonasal Debridement Procedure</intervention_name>
    <description>This is a medical procedure prescribed by the participant's physician that has been deemed necessary for patient care in order to address their chronic rhinosinusitis.</description>
    <arm_group_label>TIP-OB (Office-Based)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nasal Polyp Removal</intervention_name>
    <description>This is a surgical procedure prescribed by the participant's physician that has been deemed necessary for patient care in order to address their chronic rhinosinusitis.</description>
    <arm_group_label>TIP-OR (Operating Room)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biopsy</intervention_name>
    <description>A biopsy is optional and will remove a sample of inferior turbinate tissue from the nasal passage. It will be performed during a nasal polyp removal surgery already scheduled for patient care.</description>
    <arm_group_label>TIP-OR (Operating Room)</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Nasal polyp tissue collected from the nasal passages, inferior turbinate tissue collected&#xD;
      form the nasal passages, mucus collected from the nasal passages, induced sputum, and blood.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants with chronic rhinosinusitis who present with or without nasal polyps between&#xD;
        the ages of 18 and 80 years.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Participants with Chronic Rhinosinusitus with Nasal Polyps&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Males or females between the ages 18 to 80 (inclusive).&#xD;
&#xD;
          -  History of blood eosinophils &gt; 200 cells/dL (or tissue eosinophilia evident on&#xD;
             histopathologic review of sino-nasal tissues).&#xD;
&#xD;
          -  Physician diagnosis of chronic rhinosinusitis (CRS).&#xD;
&#xD;
          -  Undergoing office-based or operating room-based sinus procedures for a clinical&#xD;
             indication.&#xD;
&#xD;
          -  Written informed consent obtained from subject and ability for subject to comply with&#xD;
             the requirements of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smoking of tobacco or other recreational inhalants more than twice in the last month&#xD;
             and/or &gt;10 pack-year smoking history.&#xD;
&#xD;
          -  History of cystic fibrosis or ciliary dyskinesia.&#xD;
&#xD;
          -  Currently taking immunosuppressant drugs including Mycophenolate mofetil (Cellcept),&#xD;
             Cyclophosphamide (Cytoxan), Azathioprine (Imuran).&#xD;
&#xD;
        Participants with Chronic Rhinosinusitus without Nasal Polyps&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Males or females between the ages 18 to 80 (inclusive)&#xD;
&#xD;
          -  Physician diagnosis of CRS.&#xD;
&#xD;
          -  Undergoing office-based or operating room-based sinus procedures for a clinical&#xD;
             indication.&#xD;
&#xD;
          -  Written informed consent obtained from subject and ability for subject to comply with&#xD;
             the requirements of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smoking of tobacco or other recreational inhalants more than twice in the last month&#xD;
             and/or &gt;10 pack-year smoking history.&#xD;
&#xD;
          -  Presence of nasal polyps.&#xD;
&#xD;
          -  History of allergic rhinitis.&#xD;
&#xD;
          -  History of blood eosinophilia &gt; 200 (or tissue eosinophilia evident on histopathologic&#xD;
             review of sino-nasal tissues).&#xD;
&#xD;
          -  Currently taking immunosuppressant drugs including Mycophenolate mofetil (Cellcept),&#xD;
             Cyclophosphamide (Cytoxan), Azathioprine (Imuran).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Fahy, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ariana Baum</last_name>
    <phone>415-514-1539</phone>
    <email>ariana.baum@ucsf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ndidi Njoku</last_name>
    <phone>415-476-1738</phone>
    <email>ndidi.njoku@ucsf.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UCSF Airway Clinical Research Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ariana Baum</last_name>
      <phone>415-514-1539</phone>
      <email>ariana.baum@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>John Fahy, MD, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Ansel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nirav Bhakta, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erin Gordon, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Monica Tang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maya Kotas, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard Locksley, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Max Seibold, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Prescott Woodruff, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://acrc.ucsf.edu</url>
    <description>Airway Clinical Research Center website</description>
  </link>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>February 27, 2020</study_first_submitted>
  <study_first_submitted_qc>November 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2020</study_first_posted>
  <last_update_submitted>June 1, 2021</last_update_submitted>
  <last_update_submitted_qc>June 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Chronic Rhinosinusitis</keyword>
  <keyword>Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
    <mesh_term>Nasal Polyps</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

